A carregar...
Performance of factor IX extended half‐life product measurements in external quality control assessment programs
BACKGROUND: Patients with hemophilia B are increasingly treated with extended half‐life (EHL) factor IX (FIX) concentrates. For the laboratory, introduction of these EHL concentrates presents a major challenge. To understand the variation in FIX activity levels, all available diagnostic assays need...
Na minha lista:
| Publicado no: | J Thromb Haemost |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7496271/ https://ncbi.nlm.nih.gov/pubmed/32311825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.14847 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|